FRESH-PEF73991-en
Multicenter study on nosocomial transmission of SARS-CoV2 virus
NOSO-COR Project
| Name | Country code |
|---|---|
| France | fr |
| Madagascar | mg |
| Côte d'ivoire | ci |
| Mali | ml |
| Guinea | gn |
| Bangladesh | bd |
| Lebanon | lb |
['Clinical data','Biological data','Socio-demographic data','Behavioral data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Infectious disease medicine | health theme |
| Certain infectious or parasitic diseases | cim-11 |
| COVID-19 | cim-11 |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Infant (28 days to 2 years)","concept":{"vocab":"MeSH","vocabURI":"D007223"}},{"value":"Child, Preschool (2 to 5 years)","concept":{"vocab":"MeSH","vocabURI":"D002675"}},{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}},{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Any voluntary adult or child or any healthcare workers from the study participant hospital who presents an infectious syndrome including the following definitions and oral/written informed consent obtained from parent/guardian for children < 18-years-old. (upon ethical requirements at each participant site). Definitions Suspect Case: - Fever above 37.8 ° C if no antipyretics are taken; And or - Cough or pharyngeal pain or other symptom suggestive of respiratory infection. AND at least 1 of the following characteristics: - return from a trip to China, or to a country in which the increase in the incidence of infections in SARS-CoV2 has been proven; - close contact (sharing the same place of family, professional life, same plane, etc.) with a person defined as a suspected or confirmed case; - Occurring in a hospital having received at least one suspected or confirmed case of SARS-CoV2 infection. Confirmed Case - The same clinical definitions, in addition to a positive RT-PCR-type virological diagnostic result specific to SARS-CoV2.","clusion_E":""}
| Name |
|---|
| Philippe;VANHEMS |
| Name | Role |
|---|---|
| HOSPICES CIVILS DE LYON (HCL) | sponsor |
| Name |
|---|
| BILL & MELINDA GATES FOUNDATION-BMGF |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| Name |
|---|
| Fondation Mérieux-Réseau GABRIEL, I-MOVE-COVID-19 |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Observational Study
| Start | End |
|---|---|
| 2020-01-01 | 2020-12-31 |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Philippe;VANHEMS | philippe.vanhems@chu-lyon.fr |